bioAffinity Technologies (BIAF) Competitors $0.24 0.00 (-0.08%) Closing price 04:00 PM EasternExtended Trading$0.24 +0.00 (+1.26%) As of 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BIAF vs. RSLS, HTCR, SJ, VCIG, MCTR, CJMB, JOB, OFAL, EHGO, and GFAIShould you be buying bioAffinity Technologies stock or one of its competitors? The main competitors of bioAffinity Technologies include ReShape Lifesciences (RSLS), HeartCore Enterprises (HTCR), Scienjoy (SJ), VCI Global (VCIG), CTRL Group (MCTR), Callan JMB (CJMB), GEE Group (JOB), OFA Group (OFAL), Eshallgo (EHGO), and Guardforce AI (GFAI). bioAffinity Technologies vs. Its Competitors ReShape Lifesciences HeartCore Enterprises Scienjoy VCI Global CTRL Group Callan JMB GEE Group OFA Group Eshallgo Guardforce AI bioAffinity Technologies (NASDAQ:BIAF) and ReShape Lifesciences (NASDAQ:RSLS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment. Is BIAF or RSLS more profitable? ReShape Lifesciences has a net margin of -69.71% compared to bioAffinity Technologies' net margin of -152.16%. ReShape Lifesciences' return on equity of -547.65% beat bioAffinity Technologies' return on equity.Company Net Margins Return on Equity Return on Assets bioAffinity Technologies-152.16% -845.68% -181.92% ReShape Lifesciences -69.71%-547.65%-79.89% Do analysts rate BIAF or RSLS? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score bioAffinity Technologies 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00ReShape Lifesciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of BIAF or RSLS? 1.6% of bioAffinity Technologies shares are held by institutional investors. Comparatively, 22.1% of ReShape Lifesciences shares are held by institutional investors. 16.9% of bioAffinity Technologies shares are held by company insiders. Comparatively, 0.0% of ReShape Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has higher earnings & valuation, BIAF or RSLS? ReShape Lifesciences has higher revenue and earnings than bioAffinity Technologies. bioAffinity Technologies is trading at a lower price-to-earnings ratio than ReShape Lifesciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatiobioAffinity Technologies$7.68M0.89-$9.04M-$0.70-0.34ReShape Lifesciences$8.01M1.06-$7.13M-$108.27-0.03 Does the media prefer BIAF or RSLS? In the previous week, bioAffinity Technologies had 2 more articles in the media than ReShape Lifesciences. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for ReShape Lifesciences. bioAffinity Technologies' average media sentiment score of 0.52 beat ReShape Lifesciences' score of 0.00 indicating that bioAffinity Technologies is being referred to more favorably in the media. Company Overall Sentiment bioAffinity Technologies Positive ReShape Lifesciences Neutral Which has more risk & volatility, BIAF or RSLS? bioAffinity Technologies has a beta of 2.52, meaning that its stock price is 152% more volatile than the S&P 500. Comparatively, ReShape Lifesciences has a beta of 1.16, meaning that its stock price is 16% more volatile than the S&P 500. SummaryReShape Lifesciences beats bioAffinity Technologies on 8 of the 14 factors compared between the two stocks. Get bioAffinity Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for BIAF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BIAF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BIAF vs. The Competition Export to ExcelMetricbioAffinity TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.80M$3.16B$5.78B$9.93BDividend YieldN/A2.28%6.67%4.52%P/E Ratio-0.3421.1075.6726.68Price / Sales0.89464.37553.74213.18Price / CashN/A45.1137.1158.92Price / Book1.419.8611.446.09Net Income-$9.04M-$53.47M$3.28B$266.14M7 Day Performance-1.28%2.89%0.84%0.27%1 Month Performance-19.80%8.62%7.15%4.13%1 Year Performance-82.74%13.69%59.66%23.92% bioAffinity Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BIAFbioAffinity Technologies0.8131 of 5 stars$0.24-0.1%N/A-82.9%$6.80M$7.68M-0.3410RSLSReShape Lifesciences0.0152 of 5 stars$3.16-1.4%N/A-99.6%$8.49M$8.01M-0.0350Gap DownHigh Trading VolumeHTCRHeartCore Enterprises0.5365 of 5 stars$1.12-10.4%N/A+32.1%$26.11M$30.41M-111.8940Short Interest ↑Gap UpSJScienjoy1.9632 of 5 stars$0.64-6.4%N/A-34.3%$25.11M$186.78M16.07280News CoverageShort Interest ↓Gap DownHigh Trading VolumeVCIGVCI Global1.3238 of 5 stars$0.78+2.0%N/A-99.5%$24.26M$27.83M0.00102Short Interest ↓MCTRCTRL GroupN/A$1.45-5.2%N/AN/A$22.18MN/A0.0020CJMBCallan JMBN/A$4.82flatN/AN/A$21.58M$6.56M0.0035JOBGEE Group0.9458 of 5 stars$0.20+1.0%N/A-27.2%$21.47M$108.75M-0.89310News CoverageOFALOFA GroupN/A$1.44+1.4%N/AN/A$20.05MN/A0.006EHGOEshallgoN/A$0.74-0.7%N/A-68.6%$19.77M$13.47M0.00128Gap DownGFAIGuardforce AI2.6571 of 5 stars$1.11-5.9%$4.50+305.4%-3.6%$19.77M$36.35M0.001,547News CoveragePositive News Related Companies and Tools Related Companies ReShape Lifesciences Competitors HeartCore Enterprises Competitors Scienjoy Competitors VCI Global Competitors CTRL Group Competitors Callan JMB Competitors GEE Group Competitors OFA Group Competitors Eshallgo Competitors Guardforce AI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BIAF) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bioAffinity Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bioAffinity Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIAF Stock Alerts